Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Atara Biotherapeutics (ATRA) Income from Continuing Operations (2022 - 2026)

Atara Biotherapeutics filings provide 5 years of Income from Continuing Operations readings, the most recent being 4145000.0 for Q1 2026.

  • On a quarterly basis, Income from Continuing Operations fell 110.91% to 4145000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was 42204000.0, a 169.83% decrease, with the full-year FY2025 number at 49000.0, up 99.94% from a year prior.
  • Income from Continuing Operations hit 4145000.0 in Q1 2026 for Atara Biotherapeutics, up from 36143000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 38010000.0 in Q1 2025 to a low of 88105000.0 in Q1 2022.
  • Median Income from Continuing Operations over the past 5 years was 31752000.0 (2024), compared with a mean of 34963470.59.
  • Biggest five-year swings in Income from Continuing Operations: crashed 485.08% in 2023 and later soared 219.71% in 2025.
  • Atara Biotherapeutics' Income from Continuing Operations stood at 74677000.0 in 2022, then grew by 18.72% to 60699000.0 in 2023, then surged by 79.09% to 12693000.0 in 2024, then plummeted by 184.75% to 36143000.0 in 2025, then soared by 88.53% to 4145000.0 in 2026.
  • The last three reported values for Income from Continuing Operations were 4145000.0 (Q1 2026), 36143000.0 (Q4 2025), and 4303000.0 (Q3 2025) per Business Quant data.